Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours
| dc.contributor.author | Ford, J | |
| dc.contributor.author | Cummins, E | |
| dc.contributor.author | Sharma, P | |
| dc.contributor.author | Elders, A | |
| dc.contributor.author | Stewart, F | |
| dc.contributor.author | Johnston, R | |
| dc.contributor.author | Royle, P | |
| dc.contributor.author | Jones, R | |
| dc.contributor.author | Mulatero, C | |
| dc.contributor.author | Todd, R | |
| dc.contributor.author | Mowatt, G | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.University of Aberdeen | en |
| dc.date.accessioned | 2013-10-02T11:21:03Z | |
| dc.date.available | 2013-10-02T11:21:03Z | |
| dc.date.issued | 2013-07 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 386 | |
| dc.format.extent | 3516164 | |
| dc.identifier | 26791475 | |
| dc.identifier | d2eb550a-257b-4790-a159-2a33d189795e | |
| dc.identifier | 23870108 | |
| dc.identifier | 84881078296 | |
| dc.identifier.citation | Ford, J, Cummins, E, Sharma, P, Elders, A, Stewart, F, Johnston, R, Royle, P, Jones, R, Mulatero, C, Todd, R & Mowatt, G 2013, 'Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours', Health Technology Assessment, vol. 17, no. 29, pp. 1-386. https://doi.org/10.3310/hta17290 | en |
| dc.identifier.doi | 10.3310/hta17290 | |
| dc.identifier.iss | 29 | en |
| dc.identifier.issn | 2046-4924 | |
| dc.identifier.uri | http://hdl.handle.net/2164/2948 | |
| dc.identifier.vol | 17 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Health Technology Assessment | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours | en |
| dc.type | Journal article | en |
